tiprankstipranks
Advertisement
Advertisement

NNVC Stock Latest News

NanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
The FlyNanoViricides announces NV-387 granted ODD by U.S. FDA OOPD
2d ago
NNVC
NanoViricides measles virus treatment granted FDA orphan status
PremiumThe Fly
NanoViricides measles virus treatment granted FDA orphan status
8d ago
NNVC
NanoViricides says NV-387 can help control spread of measles
PremiumThe Fly
NanoViricides says NV-387 can help control spread of measles
15d ago
NNVC
NanoViricides files application for RPDD for NV-387 with U.S. OPDD
PremiumThe Fly
NanoViricides files application for RPDD for NV-387 with U.S. OPDD
29d ago
NNVC
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
PremiumThe Fly
NanoViricides plans to commence Phase II trial of NV-387 for Monkeypox
1M ago
NNVC
NanoViricides completes manufacture of NV-387 oral gummies
PremiumThe FlyNanoViricides completes manufacture of NV-387 oral gummies
2M ago
NNVC
NanoViricides files application for orphan drug designation for NV-387
Premium
The Fly
NanoViricides files application for orphan drug designation for NV-387
3M ago
NNVC
NanoViricides files application for orphan drug designation for NV-387
Premium
The Fly
NanoViricides files application for orphan drug designation for NV-387
3M ago
NNVC
NanoViricides comments on need for broad-spectrum antivirals
PremiumThe Fly
NanoViricides comments on need for broad-spectrum antivirals
4M ago
NNVC
NanoViricides initiated with a Buy at Alliance Global
PremiumThe Fly
NanoViricides initiated with a Buy at Alliance Global
5M ago
NNVC
NanoViricides files to sell 7.14 shares of common stock for holders
PremiumThe Fly
NanoViricides files to sell 7.14 shares of common stock for holders
5M ago
NNVC
NanoViricides signs Master Services Agreement with Only Orphans Cote
PremiumThe Fly
NanoViricides signs Master Services Agreement with Only Orphans Cote
5M ago
NNVC
NanoViricides Holds 2025 Annual Stockholders Meeting
PremiumCompany AnnouncementsNanoViricides Holds 2025 Annual Stockholders Meeting
5M ago
8K
NNVC
NanoViricides reports Q3 EPS (10c) vs. (23c) last year
Premium
The Fly
NanoViricides reports Q3 EPS (10c) vs. (23c) last year
6M ago
NNVC
NanoViricides Secures $6 Million Through Securities Offering
Premium
Company Announcements
NanoViricides Secures $6 Million Through Securities Offering
6M ago
8K
NNVC
NanoViricides prices 3.57M shares at $1.68 in registered direct offering
PremiumThe Fly
NanoViricides prices 3.57M shares at $1.68 in registered direct offering
6M ago
NNVC
NanoViricides receives approval to start Phase II trial of NV-387
PremiumThe Fly
NanoViricides receives approval to start Phase II trial of NV-387
6M ago
NNVC
NanoViricides says NV-387 shows ‘strong antiviral activity’
PremiumThe Fly
NanoViricides says NV-387 shows ‘strong antiviral activity’
7M ago
NNVC
NanoViricides says NV-387 shows ‘strong activity’ against Measles virus
PremiumThe Fly
NanoViricides says NV-387 shows ‘strong activity’ against Measles virus
7M ago
NNVC
NanoViricides files annual report on Form 10-K
PremiumThe FlyNanoViricides files annual report on Form 10-K
7M ago
NNVC
NanoViricides says NV-387 could help reduce metastatic cancer resurgence
Premium
The Fly
NanoViricides says NV-387 could help reduce metastatic cancer resurgence
9M ago
NNVC
NanoViricides says NV-387 is ‘weapon necessary’ for combatting measles
Premium
The Fly
NanoViricides says NV-387 is ‘weapon necessary’ for combatting measles
9M ago
NNVC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >